Gala Early Feasibility Study of RheOx
NCT03631472
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Bronchitis
Copd Bronchitis
Interventions
DEVICE:
RheOx
Sponsor
Gala Therapeutics, Inc.